UHS Stock Forecast & Price Target

Universal Health Services is positioned to benefit from a high-quality mix of scale, margin, and optionality, with behavioral health generating over 55% of pretax profits despite being a smaller share of revenue and supported by 346 inpatient centers plus outpatient expansion. Even after a tough 3Q26 EBITDA result and slower de novo ramp, the business showed 4.0% year-over-year behavioral revenue growth, 2.1% pricing growth, and improving labor efficiency, suggesting the core can stabilize as management executes on cost controls and capacity buildout. The company’s concentration in Nevada, Texas, and California, along with a modest UK contribution, adds geographic diversification, while expected easier comps, TALK synergies, and maturation of new facilities create a credible path to better margins and stronger execution.

Universal Health Services is facing a deteriorating operating backdrop as 2026 guidance is effectively skewing toward the low end of its $2.610B–$2.717B Adj. EBITDA-NCI range, pressured by an $85M HIX headwind, a $35M California staffing drag, and $80M–$100M of EBITDA loss from slower-than-expected Cedar Hill and Florida ramp-up and Laurel Ridge decertification. Acute care volumes are weakening, with surgeries down 0.7% y/y and a 17% y/y drop in HIX volume, while pricing fell 1.7% y/y as procedures migrate to ASCs and physician offices and reimbursement mix worsens. Despite behavioral health generating over 55% of pretax profits, the company’s concentration in Nevada, Texas, and California, plus its UK exposure, leaves it vulnerable to policy, labor, and demand shocks that could further pressure margins and free cash flow.